Literature DB >> 9657768

Full activity from human beta-globin locus control region transgenes requires 5'HS1, distal beta-globin promoter, and 3' beta-globin sequences.

P Pasceri1, D Pannell, X Wu, J Ellis.   

Abstract

The locus control region (LCR) activates high-level human beta-globin transgene expression. LCR cassettes composed of 5'HS2-4 linked to the 815 bp beta-globin proximal promoter do not express fully. Here, we show that LCR (5'HS2-4) beta-globin transgenes that also contain either 5'HS1 or the distal promoter fail to express fully in single- and low-copy transgenic mice. In contrast, full expression is obtained in the presence of both 5'HS1 and the distal promoter. Nine factor binding sites were identified in 5'HS1, using in vitro DNaseI footprint and gel retardation assays, and these include a strong Sp1/Sp3 site, four GATA-1 sites, and two sites that encompass an ACTAAC motif. LCR (5'HS1-4) beta-globin transgene constructs with the distal promoter deleted or replaced by spacer DNA show that specific distal promoter sequences are required for full expression. An LCR (5'HS1-4) transgene construct with truncated downstream beta-globin gene sequences indicates that 3' sequences also play an important role. These results show that full expression of the beta-globin gene directed by the LCR requires 5'HS1, the distal beta-globin promoter, and 3' sequences, and has implications for gene therapy construct design and models of LCR activation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9657768

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Evaluation of optimal expression cassette in retrovirus vector for beta-thalassemia gene therapy.

Authors:  Wen-Ji Dong; Bin Li; De-Pei Liu; Zhen-Xiang Zu; Jia Li; De-Long Hao; Guang Liu; Zhi-Chen Guo; Chih-Chuan Liang
Journal:  Mol Biotechnol       Date:  2003-06       Impact factor: 2.695

2.  Nuclear matrix association of the human beta-globin locus utilizing a novel approach to quantitative real-time PCR.

Authors:  G Charles Ostermeier; Zhandong Liu; Rui Pires Martins; Rikki R Bharadwaj; James Ellis; Sorin Draghici; Stephen A Krawetz
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

3.  Amelioration of retroviral vector silencing in locus control region beta-globin-transgenic mice and transduced F9 embryonic cells.

Authors:  C S Osborne; P Pasceri; R Singal; T Sukonnik; G D Ginder; J Ellis
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  Deletion of the human beta-globin LCR 5'HS4 or 5'HS1 differentially affects beta-like globin gene expression in beta-YAC transgenic mice.

Authors:  Halyna Fedosyuk; Kenneth R Peterson
Journal:  Blood Cells Mol Dis       Date:  2007-04-11       Impact factor: 3.039

5.  Globin vector regulatory elements are active in early hematopoietic progenitor cells.

Authors:  Annalisa Cabriolu; Ashlesha Odak; Lee Zamparo; Han Yuan; Christina S Leslie; Michel Sadelain
Journal:  Mol Ther       Date:  2022-03-02       Impact factor: 12.910

6.  Locus control region elements HS1 and HS4 enhance the therapeutic efficacy of globin gene transfer in beta-thalassemic mice.

Authors:  Leszek Lisowski; Michel Sadelain
Journal:  Blood       Date:  2007-10-05       Impact factor: 22.113

7.  Sp1 and AP2 regulate but do not constitute TATA-less human TAF(II)55 core promoter activity.

Authors:  Tianyuan Zhou; Cheng-Ming Chiang
Journal:  Nucleic Acids Res       Date:  2002-10-01       Impact factor: 16.971

8.  Lentiviral vector ALS20 yields high hemoglobin levels with low genomic integrations for treatment of beta-globinopathies.

Authors:  Laura Breda; Valentina Ghiaccio; Naoto Tanaka; Danuta Jarocha; Yasuhiro Ikawa; Osheiza Abdulmalik; Alisa Dong; Carla Casu; Tobias D Raabe; Xiaochuan Shan; Gwenn A Danet-Desnoyers; Aoife M Doto; John Everett; Frederic D Bushman; Enrico Radaelli; Charles A Assenmacher; James C Tarrant; Natalie Hoepp; Ryo Kurita; Yukio Nakamura; Virginia Guzikowski; Kim Smith-Whitley; Janet L Kwiatkowski; Stefano Rivella
Journal:  Mol Ther       Date:  2021-01-29       Impact factor: 11.454

9.  Beta-globin LCR and intron elements cooperate and direct spatial reorganization for gene therapy.

Authors:  Alla Buzina; Mandy Y M Lo; Angela Moffett; Akitsu Hotta; Eden Fussner; Rikki R Bharadwaj; Peter Pasceri; J Victor Garcia-Martinez; David P Bazett-Jones; James Ellis
Journal:  PLoS Genet       Date:  2008-04-11       Impact factor: 5.917

10.  LCR 5' hypersensitive site specificity for globin gene activation within the active chromatin hub.

Authors:  Kenneth R Peterson; Halyna Fedosyuk; Susanna Harju-Baker
Journal:  Nucleic Acids Res       Date:  2012-10-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.